Congenital melanocytic nevi management: answer by Guida, Stefania et al.
1/3
www.jpnim.com Open Access eISSN: 2281-0692
Journal of Pediatric and Neonatal Individualized Medicine 2016;5(1):e050128
doi: 10.7363/050128 
Received: 2015 Aug 27; revised: 2015 Sept 02; rerevised: 2015 Dec 24; accepted: 2016 Jan 23; 
published online: 2016 Mar 30
Congenital melanocytic nevi 
management: answer
Stefania Guida1, Giacomo Giovanni Urtis2, Giuseppe Rubino2, Giovanni 
Pellacani1, Francesca Farnetani1
1Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
2Istituto DermoEstetico (IDE), Milan, Italy
Keywords
Melanocytic nevi, congenital nevi, melanoma, management.
Corresponding author
Stefania Guida, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy; email: 
stefania.guida@alice.it.
How to cite
Guida S, Urtis GG, Rubino G, Pellacani G, Farnetani F. Congenital melanocytic nevi management: 
answer. J Pediatr Neonat Individual Med. 2016;5(1):e050128. doi: 10.7363/050128.
Answers 
1. Treatment of congenital melanocytic nevi (CMN) is taken into account 
above all for cosmetic reasons. The probability to develop a cutaneous 
malignant melanoma is low.
2. Full- and partial-thickness procedures can be considered, depending on 
the size of the lesion and potential results.
3. The approach depends on several factors: characteristics (signs of 
malignancy, size) and location of the lesion, the will and the age of the 
patient. Some authors recommend the treatment between 2 and 5 years 
of age but no better outcomes with early intervention have been proven.
Answer
The questions can be found in the following article:
Guida S, Urtis GG, Rubino G, Pellacani G, Farnetani F. Congenital melanocytic nevi management: 
question. J Pediatr Neonat Individual Med. 2016;5(1):e050127. doi: 10.7363/050127.
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Introduction
CMN are melanocytic lesions presenting at 
birth or appearing during the first weeks of life 
[1]. CMN are usually grouped, according to size, 
in three categories: 1) small congenital nevi (SCN), 
measuring less than 1.5 cm in greatest diameter; 
2) intermediate congenital nevi (ICN) that are 1.5-
19.9 cm in greatest diameter; 3) large or giant nevi, 
larger than 20 cm in greatest diameter [2]. Although 
the risk of a nevus evolving into a melanoma is 
low, all congenital nevi, particularly giant nevi, 
can be considered potential melanoma precur- 
sors [3, 4]. Furthermore, other criteria should be 
considered for an appropriate management of these 
lesions.
Management of congenital melanocytic nevi
CMN can be treated for cosmetic reasons when 
located in aesthetic areas [5].
Full- and partial-thickness procedures are avail- 
able but the effectiveness of either strategy for 
preventing future malignancy remains controversial. 
Nevertheless, full-thickness excision improves cos- 
metic appearance for many SCN and ICN while 
partial-thickness removal approaches, such as derm- 
abrasion or lasers, may be considered when more 
aggressive surgical procedures are not practicable [5].
Moreover, some authors recommend the treat- 
ment between 2 and 5 years of age but no better 
outcomes with early intervention have been 
proven [6]. Consequently, clinical monitoring and 
subsequent excision can be considered in order to 
avoid general anesthesia, to prevent psychosocial 
consequences.
Discussion
We presented the case of a 12-year-old girl with 
a congenital melanocytic nevus on the face with 
greatest diameter of 2.5 cm. 
The management of CMN can be challenging. 
Early and complete surgical excision of giant con- 
genital nevi is advisable while the excision of 
SCN and ICN remains controversial. In fact, the 
probability of a melanoma arising in SCN and ICN is 
less than 1% of cases. This means that prophylactic 
removal of such lesions is not always necessary [7], 
although some exceptions can be considered. In fact, 
larger medium-sized CMN, as well as those with 
unusual features, those of great cosmetic concern or 
anxiety, and those that are not easy to follow-up can 
be subjected to surgical treatment [8-10]. 
Furthermore, Kruk-Jeromin et al. [11] found that 
nevi < 5 cm in diameter can be successfully excised 
with a single procedure with high rates of satisfaction, 
like in the case presented (Fig. 1).
Taking into account the size and the location on 
the face and consequent psychosocial factors, it 
was possible to consider the excision of the nevus 
in our case. This study underlines that every patient 
with a congenital melanocytic nevus needs a careful 
evaluation in order to guarantee a correct management.
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Figure 1. Clinical picture before (A) and after (B) the surgery.
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